High-Quality Bedaquiline 845533-86-0: Effective Pharmaceutical Ingredient for TB Treatment

A vital pharmaceutical ingredient for combating multi-drug-resistant tuberculosis with proven efficacy and safety.

Get a Quote & Sample

Advantages Offered

Targeted Efficacy Against MDR-TB

Bedaquiline provides a targeted approach, offering significant benefits in the fight against multi-drug-resistant tuberculosis, a growing global health concern.

Novel Mechanism of Action

Its unique mechanism of inhibiting ATP synthase offers a new pathway for treatment, crucial for overcoming resistance mechanisms seen in tuberculosis.

Global Health Recognition

Being on the WHO's list of essential medicines underscores its importance and broad acceptance in public health strategies for tuberculosis control.

Key Applications

Multidrug-Resistant Tuberculosis (MDR-TB) Treatment

This pharmaceutical ingredient is specifically designed for use in combination therapies to treat complex cases of drug-resistant tuberculosis.

Pharmaceutical Intermediate Supply

Serves as a crucial intermediate in the synthesis of advanced pharmaceutical products for infectious diseases.

Medical Research and Development

Valuable for ongoing research into new tuberculosis treatments and understanding drug resistance patterns.

Active Pharmaceutical Ingredient (API) Manufacturing

High-quality API for the reliable manufacturing of life-saving medications.

Why Choose Us?

Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.

Global Experience

With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.

Advanced Facilities

Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.

Seamless Scalability

We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).